Navigation Links
Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region
Date:2/2/2009

ST. JOSEPH, Mich., Feb. 2 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that QFAB has licensed MetaCore and entered a co marketing agreement with GeneGo for the Asia Pacific region. QFAB will have GeneGo certified experts on staff to run training classes in the region and support the local research community. QFAB will make MetaCore pathway tools, software and manually curated databases accessible to Australian and New Zealand academics as part of its delivery of tailored bioinformatics solutions to life science researchers in the region.

Jeremy Barker, QFAB's Chief Executive Officer said, "We are currently using MetaCore for an in-house project and have seen the power that it provides in a systems biology framework. In partnering with GeneGo we aim to help researchers in our part of the world realize the benefits that can come from using this software."

"We are very excited about this relationship as we will work together to open up and support Australia, New Zealand and beyond," said Julie Bryant, GeneGo's VP of Business development. "We will be jointly supporting a lot of marketing and research activities in the region as there is a lot of exciting and novel research we would like to be involved in."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.2(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.2(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.


'/>"/>
SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Open Biosystems Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland
2. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
3. Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility
4. Hovione Buys Pfizers Loughbeg API Facility
5. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
6. Vicenza Hospital Becomes First European Facility to Purchase Its Second CyberKnife System
7. Nikon Instruments Provides Donation to Help Clemson University Start New Core Microscopy Facility
8. BioLife Solutions Credit Facility Increased to $9 Million
9. Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
10. Blanchette Rockefeller Neurosciences Institute Hosts First-Ever International Forum on Memory and Memory Disorders and Dedicates New $30 Million Research Facility
11. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology:
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems is ... log work hours, for employers to make sure the right employees are actually signing ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
Breaking Biology News(10 mins):